Status:
COMPLETED
Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol
Lead Sponsor:
University of California, San Diego
Conditions:
Anxiety Disorders
Depression
Eligibility:
All Genders
21-55 years
Phase:
NA
Brief Summary
The proposed project aims to test the cognitive and neural effects of a cognitive training in a sample of individuals seeking treatment for anxiety, depression, or traumatic stress symptoms. Participa...
Detailed Description
Mood, anxiety, and traumatic stress disorders are common psychiatric conditions - affecting over 40 million U.S. adults - and are leading causes of disability worldwide. People with these conditions a...
Eligibility Criteria
Inclusion
- age 21-55
- fluent in English
- diagnosis of mood, anxiety, or traumatic stress disorder
- clinically elevated repetitive negative thinking
- outpatient status
- 6-week stability if taking selective serotonin reuptake inhibitor (SSRI) medications
Exclusion
- past year diagnosis of severe alcohol or moderate or greater substance use disorder
- lifetime history of psychotic or bipolar I disorder
- acute suicidality necessitating immediate clinical intervention
- neurodegenerative or neurodevelopmental disorders
- history of moderate or severe traumatic brain injury or other known neurological condition
- sensory deficits that would preclude completing tasks
- conditions unsafe for completing MRI scanning (e.g., metal in body)
- currently receiving psychosocial treatment
- currently receiving psychiatric pharmacotherapy, except SSRIs
Key Trial Info
Start Date :
October 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT04912089
Start Date
October 15 2021
End Date
June 30 2023
Last Update
July 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC San Diego
San Diego, California, United States, 92037